動物用医薬品の市場規模：地域別、範囲および予測

動物用医薬品の市場規模と予測

動物用医薬品の市場規模は、2023年に467億4,000万米ドルと評価され、2024年から2031年にかけてCAGR 7.77%で成長し、2031年には850億5,000万米ドルに達すると予測されています。獣医学は、動物の健康と福祉を研究する医学の一分野です。ペット、家畜、野生動物、動物園の動物など、多種多様な動物の病気や怪我の診断、治療、予防、管理を行う。獣医学は、解剖学、生理学、病理学、薬理学、外科学など、さまざまな学問分野の考え方や手順を応用することで、動物特有の健康課題に対処します。獣医師は、動物福祉を推進し、人獣共通感染症（動物と人間の間で広がる可能性のある病気）をコントロールすることで公衆衛生を守り、家畜検査や規制を通じて食の安全を確保し、科学研究に貢献するという重要な役割を担っています。

さらに、獣医学は臨床治療にとどまらず、動物の行動学、栄養学、繁殖学、疫学を含み、個々の動物と動物群両方の総合的な健康ニーズに対応しています。

世界の獣医学市場力学

主な市場促進要因

ペット飼育の増加と人間化：

世界のペット飼育の増加傾向と、ペットを家族の一員とみなすヒューマニゼーションが相まって、動物用医薬品の需要を押し上げています。この傾向は、より頻繁で包括的なペットのヘルスケアとウェルネス検診を促し、獣医療製品とサービスの需要を増大させる。

動物医療の進歩：

動物の診断、医薬品、予防接種における技術の進歩は、獣医学的治療の効果と効率を向上させる。遠隔医療、ウェアラブル健康モニター、高度な外科手術は、治療結果を改善し、利用可能なサービスの幅を広げることで動物医療市場の発展に寄与し、市場の成長を後押ししています。

動物の健康と福祉に対する意識の高まり：

ペットの飼い主や農家は、動物の健康と福祉の重要性をより強く認識するようになっており、その結果、積極的かつ予防的なヘルスケア方法が求められるようになっています。このような意識の高まりが、予防接種、栄養補助食品、定期的な健康診断への需要を喚起し、動物用医薬品市場をさらに押し上げています。

家畜生産と家畜衛生管理の拡大：

世界的に拡大する動物性タンパク質の需要を満たすためには、動物の福祉と食の安全を確保するために適切な健康管理方法を実施しなければならないです。家畜の効果的な疾病予防と管理の必要性が、予防接種、抗菌剤、寄生虫駆除剤などの動物用医薬品の需要に拍車をかけ、市場の拡大をもたらしています。

主な課題

動物医療費の上昇：

獣医療サービスや医薬品にかかる費用が高騰しているため、特に所得の低い地域では、ペットの飼い主や家畜生産者の治療へのアクセスが制限されています。そのため、高額な治療費は定期的な獣医師の診察や予防治療を抑制し、動物の健康と福祉を損ない、市場にとって大きな障害となっています。

抗菌薬耐性（AMR）：

動物における抗生物質の過剰使用と誤用は、公衆衛生上の重大なリスクであるAMRの問題を大きくしています。この難題は、規制要件を厳しくするだけでなく、代替薬の開発を必要とし、動物用医薬品市場の感染症治療方法に影響を与えます。

サプライチェーンの脆弱性：

動物用医薬品市場は、重要な医薬品やワクチンの入手に影響を与えるサプライチェーンの混乱に対して脆弱です。原材料の制限、物流の障害、地政学的緊張のすべてが供給制限を引き起こし、動物医療の需要をうまく満たす能力を制限し、市場の拡大を阻害します。

主要動向：

遠隔医療とデジタル・ヘルス・プラットフォーム：

遠隔医療とデジタル・ヘルス・プラットフォームは、遠隔地からの診察やモニタリングを可能にし、獣医療でますます普及しています。この技術は、特に貧困地域における獣医療サービスへのアクセスを改善し、アプリケーションやウェアラブルデバイスを使用して動物の継続的な健康管理を促進します。

個別化医療と精密医療：

遺伝子検査や最新の診断法を用いて、それぞれの動物に固有のニーズに合った治療を行う個別化獣医学が重視されるようになってきています。この戦略により、治療成績が向上し、副作用が最小限に抑えられ、より正確な疾病管理戦術が可能になります。

持続可能で倫理的な実践：

倫理的配慮と持続可能性は、ますます動物医療市場に影響を及ぼしています。生態系にやさしく、倫理的に調達されたものを作り、消費する方向にシフトしています。この開発は、動物ケア手順の透明性と説明責任を求める消費者の幅広い欲求を反映しています。

獣医療サービスの拡大：

動物病院は従来の治療にとどまらず、ウェルネス・プログラム、栄養アドバイス、行動療法、鍼治療などの代替療法など、サービスを拡大しています。総合的な動物ヘルスケア・サービスへとシフトしている背景には、ペットや家畜の心身の健康の重要性に対する認識の高まりがあります。

目次

第1章 世界の動物用医薬品市場のイントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査スケジュール
• 前提条件
• 制限事項

第2章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• データの三角測量
• ボトムアップアプローチ
• トップダウンアプローチ
• 調査の流れ
• 業界専門家による主要な洞察
• データソース

第3章 エグゼクティブサマリー

• 市場概要
• エコロジーのマッピング
• 絶対的収益機会
• 市場の魅力
• 動物用医薬品の世界市場地域別分析
• 動物用医薬品の世界市場：動物タイプ別
• 動物用医薬品の世界市場：製品タイプ別
• 今後の市場機会
• 世界市場内訳
• 製品ライフライン

第4章 動物用医薬品の世界市場展望

• 世界の動物用医薬品の進化
• 促進要因
• 抑制要因
• 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析
• 価格分析
• マクロ経済分析

第5章 動物用医薬品の世界市場：動物タイプ別

• 概要
• 生産動物
• コンパニオンアニマル

第6章 動物用医薬品の世界市場：製品タイプ別

• 概要
• 医薬品
• ワクチン
• 薬用飼料添加物

第7章 動物用医薬品の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ
• 中東・アフリカ
  • アラブ首長国連邦
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第8章 世界の動物用医薬品市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展
• 企業の地域別フットプリント
• 企業の業界フットプリント
• ACEマトリックス

第9章 企業プロファイル

• Zoetis Inc
• Virbac SA
• Soparfin SCA
• Merck & Co Inc
• Evonik Industries
• Elanco Animal Health Incorporated
• Dechra Pharmaceuticals PLC
• Ceva Sante Animale
• Boehringer Ingelheim International GmbH
• Archer Daniels Midland

第10章 VERIFIED MARKET INTELLIGENCE

• VERIFIED MARKET INTELLIGENCEについて
• ダイナミックなデータの可視化

Veterinary Medicine Market Size And Forecast

Veterinary Medicine Market size was valued at USD 46.74 Billion in 2023 and is projected to reach USD 85.05 Billion by 2031, growing at a CAGR of 7.77% from 2024 to 2031. Veterinary medicine is a branch of medical science that studies the health and well-being of animals. It entails the diagnosis, treatment, prevention, and management of diseases and injuries in a wide variety of animal species, such as pets, cattle, wildlife, and zoo animals. Veterinary medicine addresses animals' particular health challenges by applying ideas and procedures from several disciplines such as anatomy, physiology, pathology, pharmacology, and surgery. Veterinarians play an important role in promoting animal welfare, protecting public health by controlling zoonotic diseases (those that can spread between animals and humans), ensuring food safety through livestock inspection and regulation, and contributing to scientific research.

Additionally, veterinary medicine goes beyond clinical care to include animal behavior, nutrition, reproduction, and epidemiology, addressing the overall health needs of both individual animals and animal groups.

Global Veterinary Medicine Market Dynamics

The key market dynamics that are shaping the veterinary medicine market include:

Key Market Drivers

Rising Pet Ownership and Humanization:

The growing global trend of pet ownership, combined with the humanization of pets such that they are considered members of the family, boosts demand for veterinary medicine. This tendency encourages more frequent and comprehensive pet healthcare and wellness checkups, hence increasing demand for veterinarian products and services.

Advancements in Veterinary Healthcare:

Technological advances in animal diagnostics, medicines, and immunizations improve the effectiveness and efficiency of veterinary treatment. Telemedicine, wearable health monitors, and sophisticated surgical procedures help to develop the veterinary medical market by improving treatment outcomes and broadening the range of services available, fueling market growth.

Growing Awareness of Animal Health and Welfare:

Pet owners and farmers are becoming more conscious of the importance of animal health and welfare, which has led to proactive and preventive healthcare methods. This increased awareness is fueling demand for immunizations, nutritional supplements, and regular health screenings, boosting the veterinary medicine market even further.

Expansion of Livestock Production and Farm Animal Health Management:

To meet the expanding worldwide demand for animal protein, appropriate health management methods must be implemented to ensure animal welfare and food safety. The requirement for effective disease prevention and control in farm animals is fueling the demand for veterinary medicines such as vaccinations, antimicrobials, and parasiticides, resulting in market expansion.

Key Challenges:

Rising Costs of Veterinary Care:

The rising expense of veterinary services and medications restricts access to treatment for pet owners and livestock producers, particularly in regions with low incomes. Thus, high costs discourage regular veterinary visits and preventive treatments, compromising animal health and welfare, and posing a significant hurdle for the market.

Antimicrobial Resistance (AMR):

Overuse and misuse of antibiotics in animals contribute to the growing problem of AMR, which poses a substantial public health risk. This difficulty needs the development of alternate medicines as well as tight regulatory requirements, which will have an impact on the way the veterinary medicine market treats infectious diseases.

Supply Chain Vulnerabilities:

The veterinary medication market is vulnerable to supply chain disruptions, which impact the availability of critical medicines and vaccines. Raw material limitations, logistical obstacles, and geopolitical tensions all cause supply limits, limiting the ability to successfully meet the demand for veterinary care, and inhibiting market expansion.

Key Trends:

Telemedicine and Digital Health Platforms:

Telemedicine and digital health platforms are becoming increasingly popular in veterinary care, allowing for remote consultations and monitoring. This technology improves access to veterinary services, particularly in poor areas, and promotes continuing health management for animals using applications and wearable devices.

Personalized and Precision Medicine:

There is a rising emphasis on personalized veterinary medicine, which uses genetic testing and modern diagnostics to adapt therapies to the unique needs of each animal. This strategy enhances treatment outcomes, minimizes adverse effects, and allows for more accurate disease management tactics.

Sustainable and Ethical Practices:

Ethical considerations and sustainability are increasingly influencing the veterinary care market. There is a shift towards creating and consuming ecologically friendly and ethically sourced items. This development reflects a broader consumer desire for transparency and accountability in animal care procedures.

Expansion of Veterinary Services:

Veterinary practices are expanding their services beyond traditional treatment to include wellness programmes, nutritional advice, behavioural therapy, and alternative therapies such as acupuncture. This shift towards comprehensive animal healthcare services is being pushed by a growing realization of the importance of mental and physical well-being in pets and livestock.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Veterinary Medicine Market Regional Analysis

Here is a more detailed regional analysis of the veterinary medicine market:

North America:

According to Verified Market Research, North America is estimated to dominate the veterinary medicine market over the forecast period. North America, especially the United States, has one of the highest pet ownership rates in the world. This large pet population creates a high demand for veterinarian services and products like of wellness checkups, surgical treatments, and medications, bolstering the region's supremacy in the veterinary medicine market.

The region has a well-developed veterinary healthcare infrastructure, which includes cutting-edge veterinary hospitals, clinics, and research facilities. This enhanced infrastructure enables the delivery of cutting-edge therapies and breakthroughs in animal health care, hence contributing to the market's expansion and development.

Furthermore, North American consumers are highly aware of the importance of pet and animal health and are willing to invest accordingly. The cultural relevance of pets as family members results in large spending on preventative care, diagnostics, and treatments, boosting the region's veterinary medicine market growth.

Europe:

Europe is home to some of the world's best veterinary research facilities and pharmaceutical businesses, which have helped to develop veterinary care significantly. Continuous investment in R&D yields breakthrough medicines and diagnostic tools, moving the veterinary medicine market ahead.

The trend of pet humanization is especially prominent in Europe, where an increasing percentage of households' pets and treated like family members. This leads to increased spending on pet healthcare, such as preventive care, wellness products, and specialized treatments, driving market expansion.

Furthermore, the rising knowledge of zoonotic illnesses in Europe, particularly following occurrences such as the COVID-19 pandemic, is shifting the emphasis to animal health as a component of public health. This increased awareness regarding zoonotic disease immunizations, diagnostics, and treatments is propelling the veterinary medicine market.

Asia Pacific:

Asia Pacific is estimated to grow at the highest CAGR during the forecast period. The region's expanding population and rising wages have raised the demand for animal protein, resulting in a major expansion in the cattle business. This expansion needs improved animal health management methods, such as preventive care and immunizations, bolstering the veterinary medication market.

Government policies and consumer demand are driving an increase in awareness and concern for animal health and welfare throughout Asia Pacific. This increased attention encourages the adoption of better healthcare practices for both pets and cattle, contributing to market growth.

Furthermore, government and corporate sector investments in veterinary healthcare infrastructure, like as hospitals, clinics, and research centers, are increasing across the Asia-Pacific region. These expenditures provide access to veterinary services and encourage the adoption of innovative healthcare technology, hence moving the veterinary medicine market forward.

Global Veterinary Medicine Market: Segmentation Analysis

The Global Veterinary Medicine Market is Segmented on the basis of Product, Animal Type, Route of Administration, Distribution Channel, and Geography.

Veterinary Medicine Market, By Product

• Drugs
• Vaccines

Based on the Product, the market is segmented into Drugs and Vaccines. The vaccines segment is estimated to dominate the veterinary medicine market. Vaccines serve an important role in preventative veterinary care because they provide protection against a wide range of infections, lowering disease outbreaks, and the need for antibiotic treatments, and eventually leading to healthier animal populations. The increased focus on animal welfare, combined with rigorous legislation for immunization of pets and animals, spurring up demand for vaccinations.

Veterinary Medicine Market, By Animal Type

• Domesticated
• Companion

Based on the Animal Type segment, the market is segmented into Domesticated and Companion. The companion animal type segment is estimated to dominate the veterinary medicine market during the forecast period due to the growing tendency of pet humanization, in which pets are increasingly seen as full members of the family. As a result, pet owners are increasingly ready to invest in their pets' health and well-being, boosting demand for a diverse variety of veterinarian services and products such as preventive immunizations, diagnostics, medicines, and nutritional supplements. Furthermore, the rise in pet ownership rates, particularly in affluent countries, is stirring up the demand for companion animal veterinarian care.

Veterinary Medicine Market, By Route Of Administration

• Oral
• Parental

Based on the Route of Administration, the market is segmented into Oral and Parental. The parental segment is estimated to exhibit the highest growth within the veterinary medicine market. The parenteral route, which includes intravenous, intramuscular, and subcutaneous injections, is critical for delivering drugs directly into the bloodstream, resulting in a faster and more regulated response than oral routes. This is especially important in treating severe or acute illnesses that require quick absorption. Parenteral treatments have a considerable market share due to their dependability and efficacy in critical care circumstances, even though they require professional administration and can cause animals more stress than oral alternatives.

Veterinary Medicine Market, By Distribution Channel

• Veterinary Hospitals & Clinics
• Retail Stores
• Online Pharmacies

Based on the Distribution Channel, the market is segmented into Veterinary Hospitals and Clinics, Retail Stores and Online Pharmacies. The veterinary hospitals & clinics segment is estimated to dominate the veterinary medicine market due to the comprehensive care and broad variety of services provided by these hospitals, which include diagnostic, treatment, surgery, and emergency care. Veterinary hospitals and clinics are the first point of contact for pet owners and livestock producers looking for expert, specialized treatment for their animals. They not only provide fast access to a wide range of veterinary pharmaceuticals, such as prescription drugs, vaccines, and treatments, but also the experience of veterinary professionals to ensure proper diagnosis and treatment regimens.

Veterinary Medicine Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the veterinary medicine market is classified into North America, Europe, Asia Pacific, and the Rest of the world. According to the VMR analyst, North America is estimated to dominate during the forecasted period. This region has a strong and advanced veterinary healthcare infrastructure, which includes world-class veterinary hospitals, clinics, and research institutions that help deliver cutting-edge care and encourage veterinary medicine advances. Furthermore, strong regulatory standards maintain high-quality care and product safety, which strengthens consumer trust and market stability.

Key Players

• The "Veterinary Medicine Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Zoetis, Merck & Co., Elanco, Boehringer Ingelheim, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Phibro Animal Health Corporation, Inventory Ally, Virbac, Bimeda Corporate, Chewy, Vetoquinol SA, Neogen Corporation, China Animal Husbandry Co., Sanofi SA, Loyal Companion, Bayer Animal Health, IDEXX Laboratories, Royal Canin SAS and Nestle Purina PetCare Company.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Veterinary Medicine Market Recent Developments
• In February 2024, Chewy, an online pet retailer, announced plans to construct brick-and-mortar veterinarian clinics in Florida and Colorado, further increasing its influence in the pet healthcare market.
• In February 2024, Loyal Companion, a pet health company, announced that they are looking for senior dogs to participate in a study that will assess the efficacy of a prospective canine longevity medicine.
• In February 2024, Inventory Ally, a cloud-based software system, won the 2024 Pet Pitch Prize competition for its contribution to streamlining inventory management and purchasing in veterinary facilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL VETERINARY MEDICINE MARKET

• 1.1 Market Definition
• 1.2 Market Segmentation
• 1.3 Research Timelines
• 1.4 Assumptions
• 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 2.1 Data Mining
• 2.2 Data Triangulation
• 2.3 Bottom-Up Approach
• 2.4 Top-Down Approach
• 2.5 Research Flow
• 2.6 Key Insights from Industry Experts
• 2.7 Data Sources

3 EXECUTIVE SUMMARY

• 3.1 Market Overview
• 3.2 Ecology Mapping
• 3.3 Absolute Market Opportunity
• 3.4 Market Attractiveness
• 3.5 Global Veterinary Medicine Market Geographical Analysis (CAGR %)
• 3.6 Global Veterinary Medicine Market, By Animal Type (USD Million)
• 3.7 Global Veterinary Medicine Market, By Product Type (USD Million)
• 3.8 Future Market Opportunities
• 3.9 Global Market Split
• 3.10 Product Life Line

4 GLOBAL VETERINARY MEDICINE MARKET OUTLOOK

• 4.1 Global Veterinary Medicine Evolution
• 4.2 Drivers
  • 4.2.1 Driver 1
  • 4.2.2 Driver 2
• 4.3 Restraints
  • 4.3.1 Restraint 1
  • 4.3.2 Restraint 2
• 4.4 Opportunities
  • 4.4.1 Opportunity 1
  • 4.4.2 Opportunity 2
• 4.5 Porters Five Force Model
• 4.6 Value Chain Analysis
• 4.7 Pricing Analysis
• 4.8 Macroeconomic Analysis

5 GLOBAL VETERINARY MEDICINE MARKET, BY ANIMAL TYPE

• 5.1 Overview
• 5.2 Production Animals
• 5.3 Companion Animals

6 GLOBAL VETERINARY MEDICINE MARKET, BY PRODUCT TYPE

• 6.1 Overview
• 6.2 Drugs
• 6.3 Vaccines
• 6.4 Medicated Feed Additives

7 GLOBAL VETERINARY MEDICINE MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Argentina
  • 7.5.3 Rest of Latin America
• 7.6 Middle-East and Africa
  • 7.6.1 UAE
  • 7.6.2 Saudi Arabia
  • 7.6.3 South Africa
  • 7.6.4 Rest of Middle-East and Africa

8 GLOBAL VETERINARY MEDICINE MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Developments
• 8.4 Company Regional Footprint
• 8.5 Company Industry Footprint
• 8.6 ACE Matrix

9 COMPANY PROFILES

• 9.1 Zoetis Inc
  • 9.1.1 Company Overview
  • 9.1.2 Company Insights
  • 9.1.3 Product Benchmarking
  • 9.1.4 Key Development
  • 9.1.5 Winning Imperatives
  • 9.1.6 Current Focus & Strategies
  • 9.1.7 Threat from Competition
  • 9.1.8 SWOT Analysis
• 9.2 Virbac SA
  • 9.2.1 Company Overview
  • 9.2.2 Company Insights
  • 9.2.3 Product Benchmarking
  • 9.2.4 Key Development
  • 9.2.5 Winning Imperatives
  • 9.2.6 Current Focus & Strategies
  • 9.2.7 Threat from Competition
  • 9.2.8 SWOT Analysis
• 9.3 Soparfin SCA
  • 9.3.1 Company Overview
  • 9.3.2 Company Insights
  • 9.3.3 Product Benchmarking
  • 9.3.4 Key Development
  • 9.3.5 Winning Imperatives
  • 9.3.6 Current Focus & Strategies
  • 9.3.7 Threat from Competition
  • 9.3.8 SWOT Analysis
• 9.4 Merck & Co Inc
  • 9.4.1 Company Overview
  • 9.4.2 Company Insights
  • 9.4.3 Product Benchmarking
  • 9.4.4 Key Development
  • 9.4.5 Winning Imperatives
  • 9.4.6 Current Focus & Strategies
  • 9.4.7 Threat from Competition
  • 9.4.8 SWOT Analysis
• 9.5 Evonik Industries
  • 9.5.1 Company Overview
  • 9.5.2 Company Insights
  • 9.5.3 Product Benchmarking
  • 9.5.4 Key Development
  • 9.5.5 Winning Imperatives
  • 9.5.6 Current Focus & Strategies
  • 9.5.7 Threat from Competition
  • 9.5.8 SWOT Analysis
• 9.6 Elanco Animal Health Incorporated
  • 9.6.1 Company Overview
  • 9.6.2 Company Insights
  • 9.6.3 Product Benchmarking
  • 9.6.4 Key Development
  • 9.6.5 Winning Imperatives
  • 9.6.6 Current Focus & Strategies
  • 9.6.7 Threat from Competition
  • 9.6.8 SWOT Analysis
• 9.7 Dechra Pharmaceuticals PLC
  • 9.7.1 Company Overview
  • 9.7.2 Company Insights
  • 9.7.3 Product Benchmarking
  • 9.7.4 Key Development
  • 9.7.5 Winning Imperatives
  • 9.7.6 Current Focus & Strategies
  • 9.7.7 Threat from Competition
  • 9.7.8 SWOT Analysis
• 9.8 Ceva Sante Animale
  • 9.8.1 Company Overview
  • 9.8.2 Company Insights
  • 9.8.3 Product Benchmarking
  • 9.8.4 Key Development
  • 9.8.5 Winning Imperatives
  • 9.8.6 Current Focus & Strategies
  • 9.8.7 Threat from Competition
  • 9.8.8 SWOT Analysis
• 9.9 Boehringer Ingelheim International GmbH
  • 9.9.1 Company Overview
  • 9.9.2 Company Insights
  • 9.9.3 Product Benchmarking
  • 9.9.4 Key Development
  • 9.9.5 Winning Imperatives
  • 9.9.6 Current Focus & Strategies
  • 9.9.7 Threat from Competition
  • 9.9.8 SWOT Analysis
• 9.10 Archer Daniels Midland
  • 9.10.1 Company Overview
  • 9.10.2 Company Insights
  • 9.10.3 Product Benchmarking
  • 9.10.4 Key Development
  • 9.10.5 Winning Imperatives
  • 9.10.6 Current Focus & Strategies
  • 9.10.7 Threat from Competition
  • 9.10.8 SWOT Analysis

10 VERIFIED MARKET INTELLIGENCE

• 10.1 About Verified Market Intelligence
• 10.2 Dynamic Data Visualization